QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: mol.106.030684v1 71/3/949    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Moreau, M. E. Articles by Marceau, F. Search for Related Content PubMed PubMed Citation Articles by Moreau, M. E. Articles by Marceau, F.

Role of Nuclear Factor-B and Protein Kinase C Signaling in the Expression of the Kinin B₁ Receptor in Human Vascular Smooth Muscle Cells

Faculté de Pharmacie, Université de Montréal, Montréal, Québec, Canada (M.E.M., A.A.); and Centre de Recherche en Rhumatologie et Immunologie, Centre Hospitalier Universitaire de Québec, Ville de Québec, Québec, Canada (M.-T.B., G.M., F.M.).

Kinin B₁ receptor expression was characterized in human umbilical artery smooth muscle cells to further elucidate the function and specificity of three previously proposed pathways [nuclear factor-B (NF-B), protein kinase C, and agonist autoregulation] that regulate this inducible G protein-coupled receptor. Radioligand binding assays, real-time reverser transcription/polymerase chain reaction with an optional actinomycin D treatment period, and NF-B immunofluorescence were primarily employed in these primary cell cultures. Various stimulatory compounds that increase receptor mRNA stability only (human and bovine sera, cycloheximide) or that stimulate NF-B nuclear translocation and both mRNA concentration and stability [interleukin (IL)-1, phorbol 12-myristate 13-acetate (PMA)] all increased the density of binding sites for the tritiated B₁ receptor agonist [³H]Lys-des-Arg⁹-bradykinin (without change in receptor affinity) in cell-based assays. Small interfering RNA assays indicated that NF-B p65 is necessary for the effective expression of the cell surface B₁ receptor under basal or IL-1, fetal bovine serum (FBS), or PMA stimulation conditions. Dexamethasone cotreatment reproduced these effects. IL-1-, FBS-, or PMA-induced stabilization of B₁ receptor mRNA was inhibited by the addition of the protein kinase C inhibitor 3-[1-[3-(dimethylamino)propyl]-1H-indol-3-yl]-4-(1H-indol-3-yl)-1H-pyrrole-2,5-dione monohydrochloride (GF-109203x), which also diminished the B_max under FBS or PMA treatment. Lys-des-Arg⁹-bradykinin had little effect on NF-B activation, the B_max, or receptor mRNA abundance or stability. Both NF-B and protein kinase C signaling are required for the effective expression of the kinin B₁ receptor in human umbilical artery smooth muscle cells.

Address correspondence to: Dr. François Marceau, Centre Hospitalier Universitaire de Québec, Centre de recherche en rhumatologie et immunology, 2705 Laurier Blvd, Ville de Québec (Québec), Canada G1V 4G2. E-mail: francois.marceau{at}crchul.ulaval.ca

This article has been cited by other articles:

				M.-T. Bawolak, L. Gera, G. Morissette, J. Bouthillier, J. M. Stewart, L.-A. Gobeil, R. Lodge, A. Adam, and F. Marceau Fluorescent Ligands of the Bradykinin B1 Receptors: Pharmacologic Characterization and Application to the Study of Agonist-Induced Receptor Translocation and Cell Surface Receptor Expression J. Pharmacol. Exp. Ther., April 1, 2009; 329(1): 159 - 168. [Abstract] [Full Text] [PDF]